GSK 249553
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK 249553, covering 2019-02-25 to 2019-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery [Phase 2]